CIN-102

· CinDome Pharma, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CIN-102, covering 2025-12-17 to 2026-03-25. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study of CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis [Phase 2]